fda warning letter semaglutide october 2025 The sent a this month to Novo Nordisk, alleging the drugmaker failed to report, in a timely manner, potential side effects in patients who took its popular medications containing Compound versions of GLP-1 drugs

R.GronowA.GilbertB.RaemyE.LamacchiaC.et al

Hypertension doesn't always begin in the heart

Aligned with this need, recently, the Ministry of Health in Indonesia established an initiative to provide support for DM management through the Diabetes Center program, which involves a team of professionals providing comprehensive diabetes care, from large hospitals to hospitals in districts

Each additional draw increases contamination risk significantly

Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics